Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) EBT Margin: 2009-2025

Historic EBT Margin for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Sep 2025 value amounting to -23.44%.

  • Cumberland Pharmaceuticals' EBT Margin fell 665.00% to -23.44% in Q3 2025 from the same period last year, while for Sep 2025 it was -8.18%, marking a year-over-year increase of 2114.00%. This contributed to the annual value of -17.08% for FY2024, which is 119.00% down from last year.
  • Cumberland Pharmaceuticals' EBT Margin amounted to -23.44% in Q3 2025, which was down 248.14% from -6.73% recorded in Q2 2025.
  • Cumberland Pharmaceuticals' 5-year EBT Margin high stood at 10.70% for Q1 2025, and its period low was -67.11% during Q4 2023.
  • Over the past 3 years, Cumberland Pharmaceuticals' median EBT Margin value was -11.08% (recorded in 2024), while the average stood at -14.18%.
  • Per our database at Business Quant, Cumberland Pharmaceuticals' EBT Margin tumbled by 4,068bps in 2023 and then skyrocketed by 4,834bps in 2024.
  • Cumberland Pharmaceuticals' EBT Margin (Quarterly) stood at -52.59% in 2021, then spiked by 2,615bps to -26.43% in 2022, then slumped by 4,068bps to -67.11% in 2023, then soared by 4,834bps to -18.77% in 2024, then slumped by 665bps to -23.44% in 2025.
  • Its EBT Margin stands at -23.44% for Q3 2025, versus -6.73% for Q2 2025 and 10.70% for Q1 2025.